Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib Study of Pembrolizumab in Combination With Chemo Radiotherapy (CRT) for Locally-advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

NCT02586207 is registered in ClinicalTrials.gov with Sanford Health as lead sponsor.

NCT NCT02586207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02586207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib Study of Pembrolizumab in Combination With Chemo Radiotherapy (CRT) for Locally-advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Lead sponsor
Sanford Health
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2015
Completion date
August 31, 2025
Enrollment
59 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, hypopharynx cancer, laryngeal cancer, larynx cancer, oral cavity cancer, oropharynx cancer, squamous cell carcinoma